Brożewicz Kamil, Sławiński Jarosław
Department of Organic Chemistry, Medical University of Gdańsk, Al. Gen. J. Hallera 107, 80-416 Gdańsk, Poland.
Monatsh Chem. 2012;143(6):975-984. doi: 10.1007/s00706-012-0732-6. Epub 2012 Mar 2.
Two series of novel 4-chloro-2-(benzylthio)-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides and their -aroyl derivatives have been synthesized and evaluated for in vitro anticancer activity against the full NCI-60 cell line panel. Most of the compounds exhibited antiproliferative activity. Among them a compound bearing an -(thien-2-ylcarbonyl) moiety showed broad-spectrum activity with 50% growth inhibition (GI) values in the range of 2.02-7.82 μM over 50 cell lines.
合成了两个系列的新型4-氯-2-(苄硫基)-5-(1,3,4-恶二唑-2-基)苯磺酰胺及其α-芳酰基衍生物,并针对完整的NCI-60细胞系面板评估了其体外抗癌活性。大多数化合物表现出抗增殖活性。其中,一个带有α-(噻吩-2-基羰基)部分的化合物显示出广谱活性,在50个细胞系中50%生长抑制(GI)值在2.02-7.82 μM范围内。